Ramya Srinivasan, MD
Pediatric Critical Care Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Srinivasan’s office at (650) 498-6313 to ask if they take your plan before you enroll.
California Medical Board record
Licence A82072 · Current
Licensed to practise in California · since 2003 · expires 2028-08-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Critical Care Medicine
- American Board of Pediatrics - Pediatrics
Medicaid work
$217,005 in 2024
Medicaid paid $217,005 for 1,739 billed services this clinician did in 2024, up to 65 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 369 | $216,653 |
| Short return visit (20+ min) | 269 | $196 |
| Return visit (30+ min) | 87 | $116 |
| Short return visit | 87 | $40 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 44 | $0 |
| Medication list documented in medical record (COA) | 284 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 210 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 212 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 177 | $0 |
| 2024 | 1,739 | 9 | 65 | $217,005 |
| 2023 | 1,688 | 9 | 99 | $414,015 |
| 2022 | 1,304 | 5 | 41 | $160,444 |
| 2021 | 253 | 3 | 36 | $0 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 768 | $413,749 |
| Short return visit | 295 | $145 |
| Short return visit (20+ min) | 365 | $122 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 40 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 53 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 39 | $0 |
| New patient visit (30+ min) | 67 | $0 |
| Return visit (30+ min) | 36 | $0 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 25 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 174 | $160,444 |
| New patient visit (30+ min) | 663 | $0 |
| Short return visit (20+ min) | 215 | $0 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 15 | $0 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 237 | $0 |
2021
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 31 | $0 |
| New patient visit (30+ min) | 181 | $0 |
| Short return visit (20+ min) | 41 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 14 Part D prescriptions in 2018. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2018 | 14 | None | 0% (0) | None | $1,564 |
| 2017 | 39 | None | 0% (0) | None | $10,961 |
| 2016 | 15 | None | 0% (0) | 0% | $519 |
| 2014 | 25 | None | 0% (0) | None | $1,634 |
| 2013 | 82 | 15 | None | 33% | $29,753 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Professional record
- NPI
- 1912100611
- Licence
- CA A82072California A82072: Current · expires 2028-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0203X (2080P0203X); Pediatrics (208000000X)
- Mailing address
- 770 Welch Road, Suite 350, Stanford, CA, 94305
- NPI first listed
- 2007-06-08
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.